J&J Study Shows Procrit Boosts Hemoglobin (IWon - Money)

home   >   yahoo news

ORLANDO, Fla. -(Dow Jones)- Johnson & Johnson (JNJ) said a study showed that its Procrit drug increased red blood cell levels more than Amgen Inc.'s (AMGN) Aranesp in patients with cancer and anemia caused by chemotherapy.

- link to J&J Study Shows Procrit Boosts Hemoglobin (IWon - Money) -
Last update: 05/26/2005

Recommended Reading

    Capturing Epogen[R] Overfill. : An article from: Nephrology Nursing Journal
    Advair beats combivent for patients with COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) : An article from: Internal Medicine News
    Leukotriene Users Need Fewer Oral Steroid Rescues. : An article from: Internal Medicine News
    Poltica y toros: verdad y apariencia.(ilegalizacin del partido Herri Batasuna como parte de plan para prevenir actos terroristas; Espaa)(TT: Bullfight ... pain)(Artculo Breve) : An article from: Epoca
    Intensive statin regimen may halt atherosclerosis: measured by intravascular ultrasound: 'maximally intensive ... therapy can completely halt the dise ... News) : An article from: Family Practice News
    En un acto
    Supratherapeutic dosing of olanzapine may help refractory schizophrenia. (Improved Social Functioning). : An article from: Clinical Psychiatry News
    Infliximab Maker Warns Doctors of New TB Cases. (Rheumatoid Arthritis, Crohn's).(Brief Article) : An article from: Family Practice News